paclitaxel,CTX-009
Compass Therapeutics
[]
on fri, jan 20, we present data from a phase 2 study of ctx-009 in combination with paclitaxel in patients with biliary tract cancers (btc) at #gi23: on mon, jan 23, we host an investor event 8:30 am et. info: #cmpx #biotech 
Targeting the immune synapse with a new generation of antibody therapeutics